Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons, leveraging natural mitochondrial donation capacity for neuroprotection.
Curated pathway from expert analysis
graph TD
A["Oxidative Stress and Neuronal Damage"] -->|"triggers"| B["Astrocyte Activation"]
B -->|"upregulates"| C["GJA1 Gene Expression"]
C -->|"increases"| D["Connexin-43 Protein Synthesis"]
D -->|"enhances"| E["Gap Junction Formation"]
E -->|"facilitates"| F["Astrocyte-Astrocyte Communication"]
F -->|"coordinates"| G["Tunneling Nanotube Assembly"]
D -->|"stabilizes"| G
G -->|"enables"| H["Mitochondrial Transfer Machinery"]
H -->|"transports"| I["Healthy Mitochondria to Neurons"]
I -->|"restores"| J["Neuronal ATP Production"]
I -->|"reduces"| K["Neuronal Ca2+ Overload"]
J -->|"improves"| L["Synaptic Function"]
K -->|"prevents"| M["Neuronal Apoptosis"]
L -->|"promotes"| N["Neuroprotection"]
M -->|"contributes to"| N
O["Connexin-43 Modulators"] -->|"therapeutic target"| D
classDef mechanism fill:#4fc3f7,color:#0d0d1a
classDef pathology fill:#ef5350,color:#0d0d1a
classDef therapy fill:#81c784,color:#0d0d1a
classDef outcome fill:#ffd54f,color:#0d0d1a
classDef genetics fill:#ce93d8,color:#0d0d1a
class A,K pathology
class C,D,E,F,G,H genetics
class B,I,J,L mechanism
class O therapy
class M,N outcome









Median TPM across 13 brain regions for GJA1 from GTEx v10.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GJA1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If hypothesis is true, intervention require a multi-tiered experimental approach combining in vitro and in vivo methodologies | require a multi-tiered experimental approach combining in vitro and in vivo methodologies | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention utilize primary astrocyte-neuron co-cultures to establish proof-of-concept | utilize primary astrocyte-neuron co-cultures to establish proof-of-concept | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention require careful optimization of therapeutic interventions | require careful optimization of therapeutic interventions | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature | be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms | amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms | — no observation — | pending | 0.60 |